Veress Needle in Laparoscopy: Placement and Complications

The Veress needle is a spring-loaded instrument used to inflate the abdomen with carbon dioxide gas at the start of nearly every laparoscopic surgery. It is the most common tool for creating the working space, called a pneumoperitoneum, that allows surgeons to see and operate through small incisions rather than making a large open cut. The device has an elegantly simple safety feature built into its tip, yet decades of use have revealed that getting the needle into exactly the right spot still depends heavily on the surgeon’s feel and experience, a reality that continues to drive both complication research and new technology development.

How the Needle Works

A Veress needle is essentially a hollow outer cannula with a sharp beveled tip and a blunt-tipped inner rod, called a stylet, loaded on a spring. When the surgeon pushes the needle through tissue, the resistance of the abdominal wall forces the blunt stylet to retract inside the cannula, exposing the sharp cutting edge. The moment the tip breaks through the last layer and enters the open peritoneal cavity, where resistance drops, the spring pushes the stylet forward again to cover the sharp edge. This retract-and-snap-back action is designed to prevent the exposed blade from cutting into organs or blood vessels once it’s inside the abdomen.

The catch is that the needle doesn’t stop the instant it enters the cavity. Momentum carries it forward, and the distance it overshoots depends on how much force the surgeon applied and how quickly the spring responds. A study testing a modified needle with a decoupling mechanism found that standard needles overshoot by a median of about 41 mm, while the modified version cut that roughly in half to about 21 mm.¹ That overshoot is the fundamental source of risk with this instrument: the farther the tip travels unchecked after puncture, the more likely it is to hit something it shouldn’t.

Commercially available Veress needles vary more than you might expect. Reusable models weigh roughly four times as much as disposable ones, and bevel geometries differ across manufacturers, with cutting angles ranging from 20 to 40 degrees. The spring force needed to push the stylet to the cannula tip averages less than 2 newtons, but that varies too, meaning different needles behave slightly differently when they pop through tissue.

Confirming Correct Placement

Because the surgeon can’t directly see the needle tip during blind insertion, several bedside tests have been developed to check whether the needle actually ended up in the peritoneal cavity rather than in the abdominal wall, the omentum, or somewhere worse. The most widely taught are the saline drop test (placing a drop of saline on the needle hub and watching whether it gets sucked in by negative pressure when the abdominal wall is lifted), the aspiration or recovery test, and measuring the initial insufflation pressure.

These tests are not equally reliable. A prospective clinical trial found that both the saline drop test and the recovery test had a sensitivity of only 50%, meaning they missed half of all misplacements. Their specificity was perfect, so a positive result was trustworthy, but a negative result was essentially a coin flip. By contrast, measuring the initial intraperitoneal pressure achieved 100% sensitivity and 100% specificity in the same study.² A separate study comparing Palmer’s aspiration test to a pressure profile test found a similar pattern: the pressure-based approach had higher sensitivity and specificity than aspiration alone.³

The practical takeaway is that pressure monitoring is considerably more trustworthy than the classic drop or aspiration tests, though many surgeons still use multiple checks in combination. An initial reading under about 10 mmHg typically suggests the needle is in the right place, while readings above 20 mmHg suggest it’s stuck in the abdominal wall or another wrong layer.

Where Surgeons Insert It

The default insertion site for most surgeons is the umbilicus or just below it, because the abdominal wall is thinnest there and the peritoneal cavity is closest to the skin surface. But the umbilicus is also directly above the aorta and inferior vena cava in many patients, and in anyone with previous abdominal surgery, adhesions from old scars can glue bowel loops to the underside of the abdominal wall right at that spot. This is why alternative sites exist.

Palmer’s point, located in the left upper quadrant beneath the costal margin, is the most established alternative. A randomized trial comparing three sites found Palmer’s point had the fastest pneumoperitoneum creation time, the highest first-attempt success rate at over 97%, the lowest reinsertion rate, and the best postoperative outcomes in terms of pain and hospital stay.⁴ The supraumbilical site and a newer option called Jain’s point (in the left lumbar region) were slower and required more reinsertion attempts.

A large propensity-matched analysis of over 9,400 robotic surgery patients found that umbilical insertion was associated with roughly twice the complication odds compared to Palmer’s point. However, after adjusting for other factors, the number of needle attempts and the severity of intra-abdominal adhesions mattered more than which site the surgeon chose. Patients who needed more than four insertion attempts had dramatically higher complication rates.⁵ The implication is clear: repeated stabbing at a site that isn’t working is more dangerous than switching to an alternative.

Serious Complications

The fear that keeps surgeons careful during Veress insertion is hitting a major blood vessel. Injury to a large retroperitoneal vessel occurs in somewhere between 0.3% and 1% of laparoscopic procedures, with most of these injuries happening during the entry phase, whether from the Veress needle or the primary trocar.⁶ A systematic review of Veress needle injuries specifically identified 98 vascular injuries in the published literature, of which about 8% involved the aorta, vena cava, or iliac vessels.⁷

Bowel injury is the other major concern. The small-caliber Veress needle makes smaller holes than a trocar, but a bowel perforation that goes unrecognized can lead to peritonitis. One sobering finding from insurance claim data: in a review of 41 entry-related complication claims, only about 46% of injuries were detected during the operation itself. Vascular injuries were caught intraoperatively about 70% of the time, but bowel injuries were recognized during the procedure in only 25% of cases.⁸ Delayed diagnosis of bowel perforation is what turns a manageable complication into a life-threatening one.

Minor Complications and How the Veress Needle Compares to Other Entry Methods

Major injuries during laparoscopic entry are rare with any technique. The more relevant comparison between the Veress needle and its alternatives involves the everyday, less dramatic things that go wrong. The main competitor is direct trocar insertion, where the surgeon pushes the trocar straight into the abdomen without first insufflating gas through a Veress needle. The other major alternative is the open, or Hasson, technique, where the surgeon makes a small cut-down through all abdominal layers under direct vision before placing the port.

An updated meta-analysis found no significant difference between the Veress needle and direct trocar insertion for the major complications: bowel injuries, major vascular injuries, and port-site hernias were statistically indistinguishable between the two approaches. But the Veress needle had significantly higher rates of several minor complications, including gas tracking into the wrong tissue layer (subcutaneous emphysema), gas ending up outside the peritoneal cavity (extraperitoneal insufflation), and omental bleeding. The Veress needle also had more unsuccessful entry attempts.⁹

A randomized trial comparing these two approaches found that entry time, blood loss (measured as hemoglobin decrease), and hospital stay were all higher in the Veress needle group, though the complication difference didn’t quite reach statistical significance.¹⁰ A study comparing Veress needle entry to the open Hasson technique found neither approach caused major injuries related to primary trocar placement, and both had minimal minor complications.¹¹

The persistent finding across studies is that no single entry technique has proven clearly safer than the others for serious injuries. The Veress needle’s disadvantage shows up in the minor-complication column, particularly for insufflation failures that require reinsertion. This is why the choice of technique often comes down to training, institutional culture, and the specific patient’s anatomy rather than a blanket superiority claim.

Use in Obese Patients

Morbidly obese patients present a specific challenge because the abdominal wall is much thicker, which makes umbilical insertion unreliable. The standard 120 mm Veress needle may barely reach the peritoneal cavity, and the layers of fat distort the tactile feedback surgeons rely on to feel the “pop” of peritoneal puncture. A series of 600 consecutive morbidly obese patients used a left-upper-quadrant approach with a 120 mm needle inserted just below the left costal margin. The results were remarkably clean: only one injury (a superficial puncture of the colon wall that didn’t enter the lumen), no perforations of hollow organs, no liver or spleen injuries, and no unusual bleeding.¹²

The key details from that technique include using complete muscle relaxation from anesthesia, starting gas flow at less than one liter per minute, and expecting that filling the abdomen takes four liters or more. If initial pressure readings exceed 20 mmHg, the needle is almost certainly still in the abdominal wall, not the cavity. A practical trick described by the authors: gently shaking the needle back and forth after insertion can improve gas flow from a trickle to a workable rate. For patients with extreme obesity, Palmer’s point is increasingly favored because the subcostal abdominal wall is thinner than the periumbilical region, even in very heavy individuals.

Use in Children

Pediatric patients raise different concerns. In children, the abdominal wall is thin and the peritoneal cavity is small, which means the needle enters quickly and has less room to overshoot safely. Organs are proportionally closer together. Despite these theoretical risks, the available evidence suggests the Veress needle is safe in pediatric practice. A series of 258 pediatric laparoscopies reported preperitoneal insufflation in 7% of cases, but none resulted in vessel or organ injury, none required conversion to open surgery, and in every case, simply pulling the needle back and reinserting at a different angle solved the problem.¹³

A much larger study covering over 3,400 pediatric patients found a bowel injury rate of 0.06% and a failed entry rate of 0.26%. The only significant risk factor for bowel injury was a history of previous abdominal surgery, which presumably reflects adhesions binding bowel to the anterior abdominal wall.¹⁴ In children, the main thing surgeons adjust is the depth of insertion and the volume of gas used, since a toddler’s abdomen reaches adequate distension with far less CO2 than an adult’s.

What Happens After Insufflation

Once the Veress needle is in place and gas starts flowing, the rising pressure inside the abdomen doesn’t just create a workspace for surgery. It also compresses blood vessels and shifts blood flow in ways the anesthesia team needs to manage. The standard target pressure for laparoscopic surgery is around 12 to 15 mmHg, which is enough to maintain the gas dome but low enough to avoid severe physiological effects.

Animal studies have mapped these changes in detail. At an intra-abdominal pressure of 16 mmHg, blood flow through the superior mesenteric artery and portal vein dropped progressively over a three-hour period, returning to normal after the gas was released. Hepatic arterial flow stayed relatively stable, likely due to the liver’s built-in compensatory mechanisms, but systemic vascular resistance rose as the pressurized abdomen squeezed the capillary beds in the gut.¹⁵ A separate study focused on the inferior vena cava found that flow through it dropped by roughly a quarter within five minutes of insufflation and by about a third at one hour. Paradoxically, cardiac output actually rose during the same period, possibly because the compressed abdomen pushed blood from the splanchnic bed into the central circulation before venous return declined enough to reduce it.¹⁶

For healthy patients undergoing routine laparoscopy, these shifts are well tolerated. They matter most for people with heart failure, severe lung disease, or other conditions where the cardiovascular system has little reserve. The anesthesiologist monitors these effects in real time, adjusting ventilation and fluid management as needed.

The Legal Side of Entry Injuries

Laparoscopic entry injuries account for a disproportionate share of malpractice claims in surgery, partly because patients undergoing straightforward procedures like gallbladder removal or diagnostic laparoscopy do not expect to wake up with a major complication. A review of insurance claims from a large physician insurers’ association examined 246 cases across the United States and internationally and found that most injuries involved trocars of various types, with needle injuries noted in 39 cases. The authors concluded that no needle-trocar system can guarantee avoidance of injury, especially when the trajectory puts major vessels at risk.¹⁷

A Dutch review of 41 entry-related claims spanning 13 years found that these injuries made up 18% of all laparoscopy-related claims. Most involved young women having routine, non-complex procedures planned as day surgery. Vascular injury was exclusively associated with closed entry techniques, meaning the Veress needle and blind trocar insertion rather than the open approach. Nearly two-thirds of patients ended up in the intensive care unit for a median of five days, and a payment was made in 57% of settled claims.¹⁸ The legal vulnerability for surgeons doesn’t come from the injury itself so much as from delayed recognition. An intraoperative injury that’s caught and repaired immediately has a defensible narrative; one discovered days later when the patient returns septic does not.

Training with Simulators

One frustration with teaching Veress needle insertion is that the critical skill is tactile. The surgeon needs to feel the difference between tissue layers and recognize the moment the needle pops through the peritoneum. That is hard to teach on paper or in a lecture. Virtual reality simulators with haptic (force-feedback) technology are being developed to fill this gap. A VR simulator designed specifically for Veress needle placement showed potential for helping trainees develop the necessary hand-feel skills in a risk-free environment, allowing extended practice without putting patients in danger.¹⁹

Simulation matters here because the learning curve for Veress needle insertion isn’t like learning to suture, where you can see what you’re doing and gradually get better. The entry step is essentially blind, and the feedback loop is binary: either the needle went to the right place or it didn’t. Trainees get relatively few opportunities to practice on real patients under supervision before they’re expected to do it independently, which makes the case for simulation stronger than for many other surgical skills.

Optical Guidance and Machine Learning

The most ambitious attempt to make the Veress needle safer may be removing the guesswork entirely. Researchers have developed systems that thread an optical coherence tomography (OCT) fiber probe through the needle, giving the surgeon real-time imaging of the tissue layers the needle is passing through. One system used convolutional neural networks to automatically classify the tissue type at the needle tip and estimate the remaining distance to the peritoneal cavity, achieving a tissue classification accuracy of over 98%.²⁰

A more recent iteration combined OCT imaging with machine learning classifiers to identify four distinct tissue features that differentiate the peritoneum from the layers above and below it. The best-performing classifier achieved nearly 99% precision in identifying peritoneal and surrounding tissues.²¹ If these systems move from the laboratory to the operating room, the Veress needle would transform from a blind instrument that relies on tactile feedback into a guided one that tells the surgeon exactly where the tip is at every moment. Whether the added complexity and cost are justified for a step that takes an experienced surgeon only seconds will be the real question in clinical adoption.